These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 16461089

  • 1. Role of prostate biopsy schemes in accurate prediction of Gleason scores.
    Mian BM, Lehr DJ, Moore CK, Fisher HA, Kaufman RP, Ross JS, Jennings TA, Nazeer T.
    Urology; 2006 Feb; 67(2):379-83. PubMed ID: 16461089
    [Abstract] [Full Text] [Related]

  • 2. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR, McNeal JE, Gill H, Presti JC.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):386-91. PubMed ID: 15145152
    [Abstract] [Full Text] [Related]

  • 3. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT, Eroglu A, Sahin A, Zorlu F, Ozen H.
    Urol Oncol; 2007 Jun 01; 25(5):376-82. PubMed ID: 17826653
    [Abstract] [Full Text] [Related]

  • 4. Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores.
    Miyake H, Kurahashi T, Takenaka A, Hara I, Fujisawa M.
    Urol Int; 2007 Jun 01; 79(4):302-6. PubMed ID: 18025846
    [Abstract] [Full Text] [Related]

  • 5. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F.
    Urology; 2009 May 01; 73(5):1087-91. PubMed ID: 19195695
    [Abstract] [Full Text] [Related]

  • 6. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
    Kulkarni GS, Lockwood G, Evans A, Toi A, Trachtenberg J, Jewett MA, Finelli A, Fleshner NE.
    Cancer; 2007 Jun 15; 109(12):2432-8. PubMed ID: 17497649
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies.
    Kassouf W, Nakanishi H, Ochiai A, Babaian KN, Troncoso P, Babaian RJ.
    J Urol; 2007 Jul 15; 178(1):111-4. PubMed ID: 17499289
    [Abstract] [Full Text] [Related]

  • 10. Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score.
    Elabbady AA, Khedr MM.
    Eur Urol; 2006 Jan 15; 49(1):49-53; discussion 53. PubMed ID: 16314035
    [Abstract] [Full Text] [Related]

  • 11. Comparison of cancers detected at only a sextant or alternative location.
    Ochiai A, Troncoso P, Babaian RJ.
    BJU Int; 2008 Apr 15; 101(7):837-40. PubMed ID: 18070187
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Extended pattern prostate biopsy does not minimize the volume-grade bias in prostate cancer detection.
    Al-Ghamdi AM, Lockwood G, Toi A, Kulkarni GS, Evans A, Finelli A, Zlotta AR, Fleshner N.
    J Urol; 2008 Apr 15; 179(4):1332-4. PubMed ID: 18289588
    [Abstract] [Full Text] [Related]

  • 14. Validation of a prediction model for low volume/low grade cancer: application in selecting patients for active surveillance.
    Ochiai A, Trpkov K, Yilmaz A, Donnelly B, Babaian RJ.
    J Urol; 2007 Mar 15; 177(3):907-10. PubMed ID: 17296373
    [Abstract] [Full Text] [Related]

  • 15. Does prostate biopsy Gleason score accurately express the biologic features of prostate cancer?
    Stav K, Judith S, Merald H, Leibovici D, Lindner A, Zisman A.
    Urol Oncol; 2007 Mar 15; 25(5):383-6. PubMed ID: 17826654
    [Abstract] [Full Text] [Related]

  • 16. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS.
    J Urol; 2008 Oct 15; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
    Villamón-Fort R, Martínez-Jabaloyas JM, Soriano-Sarriá P, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M.
    Urol Int; 2007 Oct 15; 78(4):328-33. PubMed ID: 17495491
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.